Clinical trial
A Double-blind Placebo-controlled Trial Comparing the Efficacy and Cost-effectiveness of Inhaled Fluticason Propionate Versus Oral N-acetylcysteine in the Treatment of Patients With COPD in General Practice
NCT00184977 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind Placebo-controlled Trial Comparing the Efficacy and Cost-effectiveness of Inhaled Fluticason Propionate Versus Oral N-acetylcysteine in the Treatment of Patients With COPD in General Practice
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 1998
- Completion date
- January 31, 2003
- Enrollment
- 270
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.